Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-04

Clinical Trial Update: Tecovirimat for Treatment of Monkeypox Virus - Study Extension Providing Standard of Care Only

View source ↗

Summary

A study extension of tecovirimat for monkeypox has completed, with the extension providing standard-of-care treatment only.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tecovirimat (tecovirimat)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Mpox (Monkeypox) | Status: COMPLETED